Possibilities of hyperuricemia correction in acute decompensation of heart failure

Possibilities of hyperuricemia correction in acute decompensation of heart failure

Acute decompensation of heart failure (ADHF) is a period of the course of chronic heart failure (CHF), which is characterised by rapid aggravation/appearance of heart failure (HF) symptoms, requiring emergency hospitalisation of the patient and intensive care. ADHF is an urgent problem for modern he...

Full description

Saved in:

Bibliographic Details
Main Authors:	Laura H. Sarieva, Svetlana N. Nasonova, Marina D. Muksinova, Igor V. Zhirov, Sergey N. Tereshchenko
Format:	Article
Language:	Russian
Published:	ZAO "Consilium Medicum" 2025-01-01
Series:	Consilium Medicum
Subjects:	acute decompensation of heart failure hyperuricaemia xanthine oxidase inhibitor allopurinol
Online Access:	https://consilium.orscience.ru/2075-1753/article/viewFile/687599/202753
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Allopurinol in the complex therapy of acute decompensation of heart failure
by: Laura H. Sarieva, et al.
Published: (2025-01-01)

Dynamics of uric acid concentration against the background of early dapagliflozin use in patients with acute decompensation of heart failure
by: Laura H. Sarieva, et al.
Published: (2024-01-01)

SGLT-2 inhibitors in the management of acute decompensated heart failure
by: Anastasia E. Poskakalova, et al.
Published: (2024-11-01)

Gout: possibilities of treatment optimization
by: A. A. Klimenko, et al.
Published: (2024-12-01)

Synthesis, Cytotoxicity, Xanthine Oxidase Inhibition, Antioxidant of New Pyrazolo{3,4 d}Pyrimidine Derivatives
by: Khammas et al.
Published: (2019-12-01)

Xanthine oxidase inhibitors in asymptomatic hyperuricemia
by: O. V. Zhelyabina, et al.
Published: (2019-10-01)

HYPERURICEMIA AS A PREDICTOR OF CHRONIC HEART FAILURE
by: M. V. Ledyakhova, et al.
Published: (2015-09-01)

Some opportunities of using xanthine oxidase inhibitors
by: O. V. Zhelyabina, et al.
Published: (2019-03-01)

Therapeutic effect and mechanism of gigantol on hyperuricemia
by: Yuanfan Wu, et al.
Published: (2025-07-01)

Urate-lowering therapy for heart failure
by: O. V. Zhelyabina, et al.
Published: (2019-09-01)

Screening medicinal plant extracts for xanthine oxidase inhibitory activity
by: A. C. Ha, et al.
Published: (2022-06-01)

IMPACT OF LEVOSIMENDAN ON RENAL FUNCTION IN COMPLEX TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE
by: M. V. Lediakhova, et al.
Published: (2018-05-01)

Clinico-demographic characteristics of the patients with decompensated chronic heart failure Clinico-demographic characteristics of the patients with decompensated chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (2011-04-01)

Inhibition of Partially Purified Xanthine Oxidase Activity from renal failure patients by Theophylline and Metronidazole
by: N.I. Al-Leheebe, et al.
Published: (2023-02-01)

Unveiling the therapeutic benefits of black chokeberry (Aronia melanocarpa) in alleviating hyperuricemia in mice
by: Chin-Yuan Liu, et al.
Published: (2025-05-01)

In Silico Prediction of Maize microRNA as a Xanthine Oxidase Inhibitor: A New Approach to Treating Hyperuricemia Patients
by: Manas Joshi, et al.
Published: (2025-01-01)

Effect of Bacillus paralicheniformis Q13 on Alleviating Hyperuricemia Induced by Potassium Oxonate in Mice
by: SUO Linglan, LI Yue, JIANG Bin, LENG Yue, REN Dayong
Published: (2025-05-01)

Treatment of iron deficiency in patients after acute decompensation: a new target in the treatment of heart failure
by: I. V. Zhirov, et al.
Published: (2022-06-01)

Experience with febuxostat in a patient with severe disabling gout
by: M. S. Eliseev, et al.
Published: (2017-09-01)

The Effect of Xanthine Oxidase Inhibitors in the Prevention and Treatment of Stroke: A Systematic Review and Meta-Analysis
by: Lin Bai, et al.
Published: (2024-12-01)

A Review on Xanthine Oxidase-Based Electrochemical Biosensors: Food Safety and Quality Control Applications
by: Totka Dodevska
Published: (2025-05-01)

The Role of Xanthine Oxidase in Pregnancy Complications: A Systematic Review
by: Lorenzo Annesi, et al.
Published: (2024-10-01)

Amino Acid Patterns that Determine Antihyperuricemic Activity of Peptides: Identification and Predictive Analysis
by: Anastasia V. Smirnova, et al.
Published: (2024-12-01)

Interaction Of Propylthiouracil With Model Systems Generating A Superoxide Radical
by: Maria Valcheva-Traykova, et al.
Published: (2014-12-01)

Green tea (Camellia sinensis L.) potential to liver of hyperuricemia rats (Rattus norvegicus) fed with high purine diet
by: PUTRANTY WIDHA NUGRAHENI, et al.
Published: (2024-10-01)

Screening of medicinal plant extracts in Vietnam and investigation of their combination for preventing and treating gout
by: C. Ha Anh, et al.
Published: (2023-03-01)

PATHOPHYSIOLOGY OF ACUTE HEART FAILURE. WHAT’S NEW?
by: S. N. Tereshchenko, et al.
Published: (2016-09-01)

Accuracy of determination of the volemic status by remote dielectric sensing in comparison with computed tomography with simultaneous determination of respiratory profile using spirometry in patients with acute decompensation of heart failure
by: A. A. Syrkhaeva, et al.
Published: (2024-05-01)

Association between allopurinol and hepatocellular carcinoma: analysis of genetic risk and patient survival
by: Yu-fu Li, et al.
Published: (2025-04-01)

Relationship between xanthine oxidoreductase and renal damage in chronic kidney disease patients
by: ZHANG Yi-yuan, et al.
Published: (2020-01-01)

SERELAXIN IN THE STRATEGY OF MANAGEMENT THE PATIENTS WITH ACUTE DECOMPENSATED HEART FAILURE: FROM DECREASING OF SYMPTOMS TO THE IMPROVEMENT OF SURVIVAL
by: I. V. Zhirov, et al.
Published: (2015-09-01)

Cardiovascular safety of xanthine oxidase inhibitors: an optimistic and unfinished story
by: M. S. Eliseev, et al.
Published: (2023-08-01)

Regulation of aging by balancing mitochondrial function and antioxidant levels
by: Sawako Yoshina, et al.
Published: (2022-11-01)

Risk factors for acute decompensated heart failure in type 2 diabetes patients
by: N. A. Koziolova, et al.
Published: (2020-05-01)

Acute decompensated heart failure in patients with prediabetes: relationship with risk factors and comorbidities
by: N. A. Koziolova, et al.
Published: (2023-04-01)

A comparison of efficacy of Febuxostat and allopurinol in treatment of hyperuricemia in patients with chronic renal failure
by: CAI Hui, et al.
Published: (2016-01-01)

CLINICAL AND ECONOMICAL ASPECTS OF NOVEL APPROACHES TO THE TREATMENT OF CHRONIC HEART FAILURE DECOMPENSATION
by: S. K. Zyryanov, et al.
Published: (2015-03-01)

Modulation of gut microbiota and serum metabolome by Apostichopus japonicus derived oligopeptide in high-fructose diet-induced hyperuricemia in mice
by: Jun Zhou, et al.
Published: (2025-01-01)

Strategy of selecting the scales of risk, prognosis, and disease severity in patients with acute decompensated heart failure
by: A. G. Arutyunov
Published: (2013-04-01)

Uric Acid-Lowering Activity in Vitro and in Vivo and Mechanism of Sheep Bone Bioactive Peptides
by: LI Xiaotong, HU Guanhua, WANG Shiqi, LIU Peiqing, WANG Shengfu, WANG Furong, WULAN Hua, SUN Lina, JIN Ye, ZHAO Lihua
Published: (2025-04-01)